Alliqua BioMedical Report issue

For profit Phase 2
Founded: Yardley PA United States (1997)
Status: Acquired by Adynxx, Inc. (2018)

Organization Overview

First Clinical Trial
2015
NCT02506452
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Alliqua BioMedical, Inc | TO Pharmaceuticals